Figure 6.
Validation of candidate peptides in another cohort. (a) Relative quantitation of peptides among three cohorts by SRM analysis (N: non-cancer control, C1: stage1 cancer, C2: stage2 cancer). Graph of dot plot shows the peak area ratio of the endogenous peptide to that of the SI-peptide (*p < 0.05, **p < 0.01, N.S: not significant) (b) ROC curve analysis for discriminating between N and C1 (green line) or between N and C2 (red line). The area under the curve (AUC) for the discrimination is shown on each graph. (c) Sensitivities and specificities of target peptides in another cohort. Sensitivity and specificity are calculated as the percentage of sample using the cutoff point obtained by the training study.